Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,544
archived clinical trials in
Ovarian Cancer

Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
A Multicenter, Randomized, Phase III Comparative Study to Compare the Efficacy and Safety of Taxotere®/Carboplatin Combination Therapy Versus Sequential Therapy With Taxotere® Then Carboplatin as Second-Line Treatment of Patients With Relapsed, Platinum-Sensitive Ovarian Cancer
Status: Enrolling
Updated:  6/5/2007
Southwest Regional Cancer Center
mi
from
Austin, TX
Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
A Multicenter, Randomized, Phase III Comparative Study to Compare the Efficacy and Safety of Taxotere®/Carboplatin Combination Therapy Versus Sequential Therapy With Taxotere® Then Carboplatin as Second-Line Treatment of Patients With Relapsed, Platinum-Sensitive Ovarian Cancer
Status: Enrolling
Updated: 6/5/2007
Southwest Regional Cancer Center
mi
from
Austin, TX
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
MedStar Washington Hospital Center
mi
from
Washington,
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
Gynecologic Disease Center, Walter Reed Army Medical Center
mi
from
Washington,
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
Gynecologic Disease Center, Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
Wayne State University Kamanos Cancer Institute
mi
from
Detroit, MI
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
Wayne State University Kamanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
Duke Univ Med Ctr
mi
from
Durham, NC
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
Ohio State University
mi
from
Columbus, OH
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
Windber Research Institute
mi
from
Windber, PA
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
Windber Research Institute
mi
from
Windber, PA
Click here to add this to my saved trials
Questionnaire Study for Gynecological Cancer Survivors
Gynecologic Cancer Survivorship Survey
Status: Enrolling
Updated:  6/26/2008
Walter Reed Army Medical Center
mi
from
Washington,
Questionnaire Study for Gynecological Cancer Survivors
Gynecologic Cancer Survivorship Survey
Status: Enrolling
Updated: 6/26/2008
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Questionnaire Study for Gynecological Cancer Survivors
Gynecologic Cancer Survivorship Survey
Status: Enrolling
Updated:  6/26/2008
Ohio State University
mi
from
Columbus, OH
Questionnaire Study for Gynecological Cancer Survivors
Gynecologic Cancer Survivorship Survey
Status: Enrolling
Updated: 6/26/2008
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Low Dose Growth Hormone in Obese PCOS Women
Effects of Low Dose Growth Hormone (GH) Therapy on Insulin Sensitivity, Metabolic Profile, Adipocyte IGF-I and Insulin Signaling, Intramyocellular Lipids, and Cortisol Metabolism in Obese Women With Polycystic Ovary Syndrome (PCOS)
Status: Enrolling
Updated:  7/21/2008
Oregon Health and Science University
mi
from
Portland, OR
Low Dose Growth Hormone in Obese PCOS Women
Effects of Low Dose Growth Hormone (GH) Therapy on Insulin Sensitivity, Metabolic Profile, Adipocyte IGF-I and Insulin Signaling, Intramyocellular Lipids, and Cortisol Metabolism in Obese Women With Polycystic Ovary Syndrome (PCOS)
Status: Enrolling
Updated: 7/21/2008
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
CCRC: The Effects of Walnuts, Walnut-Oil, Almonds and Fish Oils on Glucose Homeostasis in Polycystic Ovary Syndrome (PCOS)
CCRC: Walnuts, Walnut-Oil, Glucose Homeostasis, PCOS
Status: Enrolling
Updated:  8/1/2008
Clinical and Translational Science Center Clinical Resources Center
mi
from
Mather, CA
CCRC: The Effects of Walnuts, Walnut-Oil, Almonds and Fish Oils on Glucose Homeostasis in Polycystic Ovary Syndrome (PCOS)
CCRC: Walnuts, Walnut-Oil, Glucose Homeostasis, PCOS
Status: Enrolling
Updated: 8/1/2008
Clinical and Translational Science Center Clinical Resources Center
mi
from
Mather, CA
Click here to add this to my saved trials
Low Dose Radiation Therapy as Chemosensitizer in GI/ Ovarian Tumors
GCC 0319: A Phase I/II Study of Low-Dose Upper Abdominal Radiation Therapy (UART) or Whole (W) ART as Chemosensitizer in Patients With Locally Advanced or Metastatic Tumors of the Gastrointestinal Tract or Ovary
Status: Enrolling
Updated:  6/29/2009
University of Maryland & Baltimore VA medical centre
mi
from
Baltimore, MD
Low Dose Radiation Therapy as Chemosensitizer in GI/ Ovarian Tumors
GCC 0319: A Phase I/II Study of Low-Dose Upper Abdominal Radiation Therapy (UART) or Whole (W) ART as Chemosensitizer in Patients With Locally Advanced or Metastatic Tumors of the Gastrointestinal Tract or Ovary
Status: Enrolling
Updated: 6/29/2009
University of Maryland & Baltimore VA medical centre
mi
from
Baltimore, MD
Click here to add this to my saved trials
How Our Immune System Can Help Fight Cancer
The Effect of Genetic Polymorphisms in Indoleamine 2, 3-Dioxygenase in Epithelial Ovarian Cancer
Status: Enrolling
Updated:  1/5/2010
Winthrop University Hospital
mi
from
Mineola, NY
How Our Immune System Can Help Fight Cancer
The Effect of Genetic Polymorphisms in Indoleamine 2, 3-Dioxygenase in Epithelial Ovarian Cancer
Status: Enrolling
Updated: 1/5/2010
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)
Cortisol Regulation in Polycystic Ovary Syndrome
Status: Enrolling
Updated:  8/3/2010
Oregon Health and Science University
mi
from
Portland, OR
Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)
Cortisol Regulation in Polycystic Ovary Syndrome
Status: Enrolling
Updated: 8/3/2010
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Birmingham, AL
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
New Orleans, LA
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
St. Louis, MO
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Mayfield Heights, OH
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Mayfield Heights, OH
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Oklahoma City, OK
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Abington, PA
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Abington, PA
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Nashville, TN
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Seattle, WA
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated:  10/1/2010
GSK Investigational Site
mi
from
Madison, WI
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer
Status: Enrolling
Updated: 10/1/2010
GSK Investigational Site
mi
from
Madison, WI
Click here to add this to my saved trials
Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
A Phase II Trial of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  2/3/2011
Emory University
mi
from
Atlanta, GA
Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
A Phase II Trial of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 2/3/2011
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies
The Prevalence and Predictive Factors of Pelvic Floor Disorders in Gynecologic Malignancy Survivors
Status: Enrolling
Updated:  6/8/2011
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies
The Prevalence and Predictive Factors of Pelvic Floor Disorders in Gynecologic Malignancy Survivors
Status: Enrolling
Updated: 6/8/2011
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma
A Phase I/II, Open-Label, Non-Randomized, Pilot Study of Weekly Paclitaxel, Every Four-week Carboplatin and Oral Vorinostat for Patients Newly Diagnosed With Stage III/IV Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Status: Enrolling
Updated:  6/24/2011
Gynecologic Oncology Associates
mi
from
Newport Beach, CA
Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma
A Phase I/II, Open-Label, Non-Randomized, Pilot Study of Weekly Paclitaxel, Every Four-week Carboplatin and Oral Vorinostat for Patients Newly Diagnosed With Stage III/IV Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Status: Enrolling
Updated: 6/24/2011
Gynecologic Oncology Associates
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Compromised Microcirculation in Women With Polycystic Ovary Syndrome
Compromised Microcirculation in Women With Polycystic Ovary Syndrome
Status: Enrolling
Updated:  8/5/2011
John B. Pierce Laboratory
mi
from
New Haven, CT
Compromised Microcirculation in Women With Polycystic Ovary Syndrome
Compromised Microcirculation in Women With Polycystic Ovary Syndrome
Status: Enrolling
Updated: 8/5/2011
John B. Pierce Laboratory
mi
from
New Haven, CT
Click here to add this to my saved trials
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Surgical Cytoreduction Followed by Intraoperative Intrathoracic Hyperthermic Chemotherapy Perfusion for the Management of Disseminated Pleural Malignancies
Status: Enrolling
Updated:  9/2/2011
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Surgical Cytoreduction Followed by Intraoperative Intrathoracic Hyperthermic Chemotherapy Perfusion for the Management of Disseminated Pleural Malignancies
Status: Enrolling
Updated: 9/2/2011
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Status: Enrolling
Updated:  11/21/2011
University of Nevada School of Medicine
mi
from
Las Vegas, NV
Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Status: Enrolling
Updated: 11/21/2011
University of Nevada School of Medicine
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Proteomics & Glyco-Proteomic Analysis of Follicular Fluid
Proteomics & Glyco-Proteomic Analysis of Follicular Fluid Derived From Health Patient/Donors and Polycystic Ovary Syndrome Patients
Status: Enrolling
Updated:  12/5/2011
Center for Reproductive Health
mi
from
Cincinnati, OH
Proteomics & Glyco-Proteomic Analysis of Follicular Fluid
Proteomics & Glyco-Proteomic Analysis of Follicular Fluid Derived From Health Patient/Donors and Polycystic Ovary Syndrome Patients
Status: Enrolling
Updated: 12/5/2011
Center for Reproductive Health
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Metabolic Syndrome in PCOS: Precursors and Interventions
Metabolic Syndrome in PCOS: Precursors and Interventions
Status: Enrolling
Updated:  2/7/2012
Northwestern Memorial Hospital
mi
from
Chicago, IL
Metabolic Syndrome in PCOS: Precursors and Interventions
Metabolic Syndrome in PCOS: Precursors and Interventions
Status: Enrolling
Updated: 2/7/2012
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Trial of Fenretinide/LXS Plus Ketoconazole in Recurrent Ovarian Cancer and Primary Peritoneal Carcinoma
Phase I/II Trial of Fenretinide/LXS Oral Powder (NSC 374551) Plus Ketoconazole in Recurrent Ovarian Cancer and Primary Peritoneal Carcinoma
Status: Enrolling
Updated:  3/7/2012
UTsouthwestern medical center
mi
from
Dallas, TX
Trial of Fenretinide/LXS Plus Ketoconazole in Recurrent Ovarian Cancer and Primary Peritoneal Carcinoma
Phase I/II Trial of Fenretinide/LXS Oral Powder (NSC 374551) Plus Ketoconazole in Recurrent Ovarian Cancer and Primary Peritoneal Carcinoma
Status: Enrolling
Updated: 3/7/2012
UTsouthwestern medical center
mi
from
Dallas, TX
Click here to add this to my saved trials
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
Pilot Study of Mechanical Stimulation for Prevention of Hematopoietic Cell Transplant Associated Bone Density Loss
Status: Archived
Updated:  5/11/2012
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
Pilot Study of Mechanical Stimulation for Prevention of Hematopoietic Cell Transplant Associated Bone Density Loss
Status: Archived
Updated: 5/11/2012
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Pharmacogenetics of Metformin Action in PCOS
Pharmacogenetics of Metformin Action in PCOS
Status: Enrolling
Updated:  6/7/2012
University Of Virginia General Clinical Research Center
mi
from
Charlottesville, VA
Pharmacogenetics of Metformin Action in PCOS
Pharmacogenetics of Metformin Action in PCOS
Status: Enrolling
Updated: 6/7/2012
University Of Virginia General Clinical Research Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Pharmacogenetics of Metformin Action in PCOS
Pharmacogenetics of Metformin Action in PCOS
Status: Enrolling
Updated:  6/7/2012
Virginia Commonwealth University
mi
from
Richmond, VA
Pharmacogenetics of Metformin Action in PCOS
Pharmacogenetics of Metformin Action in PCOS
Status: Enrolling
Updated: 6/7/2012
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer
Phase II Study of Single Agent Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer With No Prior PARP Exposure or Prior PARP Inhibitor Exposure
Status: Enrolling
Updated:  8/7/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer
Phase II Study of Single Agent Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer With No Prior PARP Exposure or Prior PARP Inhibitor Exposure
Status: Enrolling
Updated: 8/7/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of SJG-136 for Cisplatin- Refractory /Resistant Epithelial Ovarian
A Phase II Evaluation of SJG-136 in Women With Cisplatin-Refractory or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Status: Enrolling
Updated:  8/14/2012
Hartford Hospital Cancer Clinical Research Office
mi
from
Hartford, CT
Evaluation of SJG-136 for Cisplatin- Refractory /Resistant Epithelial Ovarian
A Phase II Evaluation of SJG-136 in Women With Cisplatin-Refractory or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Status: Enrolling
Updated: 8/14/2012
Hartford Hospital Cancer Clinical Research Office
mi
from
Hartford, CT
Click here to add this to my saved trials
Evaluation of SJG-136 for Cisplatin- Refractory /Resistant Epithelial Ovarian
A Phase II Evaluation of SJG-136 in Women With Cisplatin-Refractory or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Status: Enrolling
Updated:  8/14/2012
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Evaluation of SJG-136 for Cisplatin- Refractory /Resistant Epithelial Ovarian
A Phase II Evaluation of SJG-136 in Women With Cisplatin-Refractory or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Status: Enrolling
Updated: 8/14/2012
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Evaluation of SJG-136 for Cisplatin- Refractory /Resistant Epithelial Ovarian
A Phase II Evaluation of SJG-136 in Women With Cisplatin-Refractory or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Status: Enrolling
Updated:  8/14/2012
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Evaluation of SJG-136 for Cisplatin- Refractory /Resistant Epithelial Ovarian
A Phase II Evaluation of SJG-136 in Women With Cisplatin-Refractory or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Status: Enrolling
Updated: 8/14/2012
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Evaluation of SJG-136 for Cisplatin- Refractory /Resistant Epithelial Ovarian
A Phase II Evaluation of SJG-136 in Women With Cisplatin-Refractory or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Status: Enrolling
Updated:  8/14/2012
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Evaluation of SJG-136 for Cisplatin- Refractory /Resistant Epithelial Ovarian
A Phase II Evaluation of SJG-136 in Women With Cisplatin-Refractory or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Status: Enrolling
Updated: 8/14/2012
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Evaluation of SJG-136 for Cisplatin- Refractory /Resistant Epithelial Ovarian
A Phase II Evaluation of SJG-136 in Women With Cisplatin-Refractory or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Status: Enrolling
Updated:  8/14/2012
Virginia Commonwealth University - VCU Massey Cancer Center
mi
from
Richmond, VA
Evaluation of SJG-136 for Cisplatin- Refractory /Resistant Epithelial Ovarian
A Phase II Evaluation of SJG-136 in Women With Cisplatin-Refractory or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Status: Enrolling
Updated: 8/14/2012
Virginia Commonwealth University - VCU Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
Arizona Cancer Center
mi
from
Tucson, AZ
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
USC Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
USC Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
Cedar Sinai-Samuel Oschin Comprehensive Cancer Institute
mi
from
Los Angeles, CA
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
Cedar Sinai-Samuel Oschin Comprehensive Cancer Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
Massachusetts General Hospital
mi
from
Boston, MA
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
Oncology Consultants
mi
from
Houston, TX
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
Oncology Consultants
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer
Continuous Infusion Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer: Tumor Features and Phase II/Pharmacokinetic Evaluation
Status: Enrolling
Updated:  8/29/2012
NYU Clinical Cancer Center
mi
from
New York, NY
Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer
Continuous Infusion Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer: Tumor Features and Phase II/Pharmacokinetic Evaluation
Status: Enrolling
Updated: 8/29/2012
NYU Clinical Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials